Allurion Technologies, Inc. (ALUR) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of a loss of $1.53 per share. This compares to earnings of $2.75 per ...

Allurion Technologies Inc. (NYSE:ALUR), a leader in innovative weight loss solutions, is set to resume patient treatments in ...

Allurion Technologies Inc. (NYSE:ALUR), a leader in innovative weight loss solutions, is set to resume patient treatments in France next month following the successful resumption of product shipments.

You may begin. Good morning and thank you for joining us. Earlier today, Allurion Technologies Inc. issued a press release announcing financial results for the quarter ended March 31st ...

Allurion Technologies Inc. (NYSE:ALUR) Q1 2025 Earnings Call Transcript May 14, 2025 Allurion Technologies Inc. beats earnings expectations. Reported EPS is $0.43, expectations were $-1.53.

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less ...

NATICK, Mass., May 29, 2025--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that Dr. Shantanu Gaur, Founder and ...

Allurion Technologies Inc. (ALUR) reported a notable decline in revenue for Q1 2025, with figures decreasing to $5.6 million from $9.4 million in the same period last year. Despite the revenue ...